Welcome to our dedicated page for KKR & Co. news (Ticker: KKR), a resource for investors and traders seeking the latest updates and insights on KKR & Co. stock.
KKR & Co. Inc. (NYSE: KKR), founded in 1976 by Henry Kravis and George Roberts, is a leading global investment firm managing investments across various asset classes such as private equity, energy, infrastructure, real estate, credit, and hedge funds. Headquartered in New York, KKR aims to generate attractive investment returns through a patient and disciplined investment approach, employing world-class talent, and driving growth and value creation at the asset level.
As of March 2023, KKR boasts an impressive $577.6 billion in total managed assets, which includes $470.6 billion in fee-earning assets under management (AUM). KKR operates through two primary segments: Asset Management and Insurance. The Asset Management segment involves private markets (private equity, credit, infrastructure, energy, and real estate) and public markets (primarily credit and hedge/investment fund platforms). The Insurance segment follows KKR's acquisition of Global Atlantic Financial Group, focusing on retirement, annuity, life insurance, and reinsurance products.
KKR invests its own capital alongside its partners' capital, offering opportunities through its capital markets business. The firm's commitment to excellence and growth is evident in its strategic partnerships and significant investments, such as its recent venture with Capital Group to introduce hybrid public-private market investment solutions designed to provide broader access to alternative investments.
In recent news, KKR announced significant developments, including a strategic partnership with Capital Group and a $600 million cash acquisition of Mirus Bio by Gamma Biosciences, a life sciences platform established by KKR.
- Latest News: FS KKR Capital Corp. declared a second-quarter 2024 distribution of $0.75 per share.
- Strategic Partnerships: KKR and Capital Group join forces to create hybrid public-private market investment solutions.
- Acquisitions: Gamma Biosciences, backed by KKR, agreed to sell Mirus Bio to Merck KGaA for $600 million.
For more information, visit KKR's website or follow them on Twitter: @kkr_co.
Global Atlantic Financial Group and the Bermuda Economic Development (BEDC) concluded their Second Annual Wave of Opportunity Pitch Competition, celebrating small business innovation in Bermuda. The event, hosted at Hamilton Princess Hotel on November 21st, featured eight finalists competing for $25,000 prizes. Winners included Nico Bean (Youth Category) for Flow by Nico, and three Main Category winners: Dr. Adriene Berkeley (PsyNeu), Jekon Edness & Kian Butterfield (Bermuda Sports Radar), and Ashleigh Simons (Sade Milan Skin). The People's Choice Award of $25,000 went to Keely Trott of NBK School of Nails. The event attracted over 100 in-person attendees and 100 livestream viewers, demonstrating strong community support for local entrepreneurship.
KKR, a leading global investment firm, has announced that Co-CEO Scott C. Nuttall will present at the Goldman Sachs 2024 US Financial Services Conference on Tuesday, December 10, 2024, at 8:00AM ET. The presentation will be accessible via live webcast on KKR's Investor Center website, with a replay available afterward. KKR specializes in alternative asset management, capital markets, and insurance solutions through its subsidiary Global Atlantic Financial Group. The firm manages investment funds focused on private equity, credit, real assets, and partners with hedge fund managers.
Lighthouse, a commercial intelligence platform for the travel & hospitality industry, has secured a $370 million Series C investment led by KKR. The funding will support product innovation, strategic acquisitions, and global expansion. Lighthouse serves over 70,000 hospitality properties globally, processing 400+ terabytes of travel data daily using AI to deliver real-time insights. The platform helps revenue managers and accommodation owners optimize bookings and operations. With 700+ employees worldwide and an NPS score of 70+, Lighthouse will leverage KKR's industry experience and global network to enhance its offerings and expand into new segments.
KKR has launched its second tender offer for FUJI SOFT (TSE: 9749) through FK Co., , running from November 20 to December 19, 2024. The offer prices are set at 9,451 yen per common share, and varying amounts for share options: 1,197,200 yen (5th Series), 1,059,800 yen (6th Series), and 293,200 yen (7th Series). FUJI SOFT's Board of Directors unanimously approved and recommended the tender offer to shareholders in two resolutions on November 15 and 19, 2024.
KKR announced plans to conduct a Second Tender Offer for FUJI SOFT at 9,451 yen per share, following its successful first tender offer where it acquired a 33.97% voting rights ratio. The FUJI SOFT Board unanimously supports KKR's offer and opposes Bain Capital's proposal. The new price represents a 125.8% premium over the 12-month average closing price prior to October 2, 2023. Shareholders who participated in the first tender offer will be made whole if KKR achieves a 53.22% stake across both offers. The second tender offer is expected to launch mid-next week.
Instructure Holdings has completed its acquisition by KKR and Dragoneer in an all-cash transaction valued at approximately $4.8 billion ($23.60 per share). Following the transaction, Instructure has been delisted from the NYSE. As a leading global provider of learning management and education-tech solutions, Instructure has impacted about 200 million learners across 100+ countries, partnering with over 1,000 organizations. The company aims to achieve $1B in revenue by 2028. The acquisition is expected to accelerate Instructure's global expansion and product innovation, particularly focusing on enhancing Canvas and the Instructure Learning Ecosystem.
Instructure Holdings has been acquired by KKR and Dragoneer in an all-cash transaction valued at approximately $4.8 billion ($23.60 per share). Following the acquisition, Instructure has been delisted from the NYSE. As a leading global provider of learning management and education-tech solutions, Instructure impacts approximately 200 million learners across 100+ countries, partnering with over 1,000 organizations. The company aims to achieve $1B in revenue by 2028. The acquisition is expected to accelerate Instructure's global expansion and product innovation, particularly focusing on enhancing Canvas and the Instructure Learning Ecosystem.
KKR has successfully completed the first stage of its tender offer for FUJI SOFT, acquiring a 33.86% voting rights stake (21,413,302 common shares) and approximately 90% of existing share options. The investment firm has become FUJI SOFT's largest shareholder, positioning itself as a key player in any potential privatization efforts. A second tender offer is planned for mid-November at 8,800 yen per share, representing a 110.3% premium over the 12-month average closing price prior to October 2, 2023. Notably, about 90% of FUJI SOFT's advisors, directors, and officers supported the first tender offer by tendering their share options.
FS KKR Capital Corp (FSK) reported its Q3 2024 financial results with net investment income of $0.77 per share, unchanged from Q2 2024. The company's net asset value slightly decreased to $23.82 per share from $23.95. Total purchases were $1,136 million versus $1,321 million in sales and repayments. The board declared a Q4 2024 distribution of $0.70 per share. The portfolio's total fair value was $13.9 billion, with 67% invested in senior secured securities. The weighted average annual yield on accruing debt investments was 11.9%, down from 12.3% in Q2. Non-accrual investments improved to 1.7% of the portfolio at fair value.
Biosynth, a global supplier of critical raw materials for life sciences, has announced key leadership changes. Matt Gunnison, CEO of Gamma Biosciences, has been appointed as the new CEO, succeeding Urs Spitz, who will remain on the Board. Kieran Murphy, former President of GE Healthcare, has been named Chairman. Gunnison brings nearly two decades of healthcare and life sciences experience, while Murphy contributes extensive corporate leadership background. Additionally, Eric Simpson, previously VP at Gamma Biosciences, joins as Head of Corporate Development.
FAQ
What is the current stock price of KKR & Co. (KKR)?
What is the market cap of KKR & Co. (KKR)?
What does KKR & Co. Inc. do?
Who founded KKR & Co. Inc.?
What are the main business segments of KKR?
How much are KKR's total managed assets?
What recent strategic partnerships has KKR announced?
What recent acquisitions has KKR been involved in?
Where can I find more information about KKR & Co. Inc.?
What is KKR’s approach to investments?
How can I stay updated with KKR’s news?